Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3. European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 90101 "CREATE".
| Image |  |
|---|---|
| Description | scientific article published on 5 December 2017 |
| Author/s |
author: Sebastian Bauer Maria Debiec-Rychter Agnieszka Wozniak Piotr Rutkowski Silvia Stacchiotti |
| Publication date | December 5, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |